user

thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease

被引：1
|
作者：
Benitez, J. M. [1 ]
Garcia-Sanchez, V. [1 ]
Gisbert, J. P. [2 ,3 ]
机构：
[1] Univ Cordoba, Dept Gastroenterol, Hosp Univ Reina Sofia, IMIBIC, Cordoba, Spain
[2] Hosp Univ La Princesa, Dept Gastroenterol, IIS IP, Madrid, Spain
[3] CIBEREHD, Madrid, Spain
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2015年 / 41卷 / 05期
关键词：
CROHNS-DISEASE; PREDICTIVE FACTORS; AZATHIOPRINE; EFFICACY; THERAPY; MAINTENANCE; RELAPSE;
D O I：
10.1111/apt.13066
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：494 / 495
页数：2
相关论文
共 50 条
  • [1] Editorial: thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease
    Fraser, A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (02) : 227 - 228
  • [2] Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients
    Kennedy, N. A.
    Kalla, R.
    Warner, B.
    Gambles, C. J.
    Musy, R.
    Reynolds, S.
    Dattani, R.
    Nayee, H.
    Felwick, R.
    Harris, R.
    Marriott, S.
    Senanayake, S. M.
    Lamb, C. A.
    Al-Hilou, H.
    Gaya, D. R.
    Irving, P. M.
    Mansfield, J.
    Parkes, M.
    Ahmad, T.
    Cummings, J. R. F.
    Arnott, I. D.
    Satsangi, J.
    Lobo, A. J.
    Smith, M.
    Lindsay, J. O.
    Lees, C. W.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 40 (11-12) : 1313 - 1323
  • [3] Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates in 72 patients, a report from a district general hospital
    Radhakrishnan, P.
    Johnson, H.
    Wade, K.
    McLaughlin, S.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S453 - S453
  • [4] THIOPURINE WITHDRAWAL DURING REMISSION IN INFLAMMATORY BOWEL DISEASE: RELAPSE AND RECAPTURE RATES IN 72 PATIENTS
    Heather
    Wade, Katharine
    Radhakrishnan, Parvathy
    McLaughlin, Simon
    GUT, 2019, 68 : A60 - A60
  • [5] PREDICTIVE FACTORS OF DISEASE RELAPSE FOLLOWING THIOPURINE WITHDRAWAL FOR SUSTAINED CLINICAL REMISSION OF IBD
    Kennedy, N. A.
    Gambles, C. J.
    Musy, R. M.
    Jones, G. R.
    Arnott, I. D.
    Satsangi, J.
    Lees, C. W.
    GUT, 2012, 61 : A71 - A72
  • [6] Predictive Factors of Disease Relapse Following Thiopurine Withdrawal for Sustained Clinical Remission of IBD
    Kennedy, Nicholas A.
    Gambles, C. J.
    Musy, R. M.
    Jones, Gareth-Rhys
    Arnott, Ian D.
    Satsangi, Jack
    Lees, Charles W.
    GASTROENTEROLOGY, 2012, 142 (05) : S363 - S363
  • [7] Poor Drug Sustainability in Inflammatory Bowel Disease Patients in Clinical Remission on Thiopurine Monotherapy
    Bhairavi Balram
    Joshua Lubov
    Yves Theoret
    Waqqas Afif
    Alain Bitton
    Gary Wild
    Peter L. Lakatos
    Talat Bessissow
    Digestive Diseases and Sciences, 2021, 66 : 1650 - 1657
  • [8] Poor Drug Sustainability in Inflammatory Bowel Disease Patients in Clinical Remission on Thiopurine Monotherapy
    Balram, Bhairavi
    Lubov, Joshua
    Theoret, Yves
    Afif, Waqqas
    Bitton, Alain
    Wild, Gary
    Lakatos, Peter L.
    Bessissow, Talat
    DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (05) : 1650 - 1657
  • [9] Clinical outcomes of vedolizumab withdrawal in inflammatory bowel disease for patients in histological remission
    Blad, William
    Whitley, Lisa
    Harrow, Paul
    GUT, 2023, 72 (SUPPL_2) : A87 - A88
  • [10] No induction of thiopurine methyltransferase during thiopurine treatment in inflammatory bowel disease
    Lindqvist, M.
    Hindorf, U.
    Almer, S.
    Soderkvist, P.
    Strom, M.
    Hjortswang, H.
    Peterson, C.
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2006, 25 (9-11): : 1033 - 1037
12345